Global Market Watch:
Primarily supported by product types; Q-PCR, Assembly PCR, Inverse PCR, RT-PCR and Digital PCR the Polymerase Chain Reaction (PCR) market to witness a value of US$12 billion by 2020. Q-PCR and Digital PCR together account for more than 50% of the global market share.
Among the classification of products/tools categories, PCR machines accounts for nearly 29.2% of the overall market share; PCR Reagents stand as the fastest growing market with a CAGR of 10.8% respectively.
Based on PCR application market, Infectious Disease market is generated as fastest growing at a CAGR of 11.2% respectively.PCR Research accounts for 36.8% of the market share by 2017.
The report “Polymerase Chain Reaction (PCR) In Medical Applications - An Analytical Report, 2014-2020” reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor’s Edge
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with three major PCR techniques, product/tools and end-users application market. Further, the subdivided categories include:
- Reverse-Transcription PCR (RT-PCR)
- Digital PCR
- Assembly PCR
- Inverse PCR
- Other (Multiplex, Nested, Hot Start and Other)
- PCR Machines
- PCR Reagents
- PCR Detection Kits/Assays
- PCR Consumables
- Other (Software, Pipetting Robot & etc.,)
PCR End-Users Application
- DNA Sequencing
- DNA Cloning
- Gene Expression
- Tissue Typing
- Genetic Abnormalities
- Infectious Diseases
- Forensic Sciences &
The period considered for the PCR market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, South Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 435 leading market players are identified and 45 key companies that project improved market activities in the near future are profiled. The report consists of 371 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Key Companies Profiled
Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Complete Genomics, Inc., Epicentre® Biotechnologies, GE Healthcare (Life Sciences), Illumina, Qiagen, Inc., Dna Landmarks, Inc., Roche Diagnostics, Eppendorf AG, Cytocell Ltd, Shimadzu Biotech, Dnavision SA, Exiqon, Hokkaido System Science Co., Ltd., Ocimum Biosolutions, Ltd., HY Laboratories LTD., PerkinElmer Life Sciences & many more….